Option chain shows key data for The Greenrose Holding Co Units (1 Ord Share & 1 War)'s stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for The Greenrose Holding Co Units (1 Ord Share & 1 War).

The Greenrose Holding Co Units (1 Ord Share & 1 War) (OTC:GNRSU) Stock, Option Chain

Cannabis

Penny Stocks

Small Cap

Markets

FFNTF

GNRSU

JAZZ

MJNA

SNDL

TLRY

TRTC

UNRIVALED BRANDS INC by Unrivaled Brands, Inc.

UNRV

TSX:FAF

Benzinga’s Cannabis Hour is a live show for cannabis investors.

Watch Medical Marijuana &amp; Unrivaled Brands At The Benzinga Cannabis Hour

News

Cannabis-focused special purpose acquisition company Greenrose Acquisition Corp. (OTC: GNRSU) announced Thursday that it has signed agreements for up to $103 million in capital from SunStream Bancorp a joint venture backed by Sundial Growers Inc.

Cannabis SPAC Greenrose&#39;s Shares Soar On $103M Debt Capital Agreement With Sundial Affiliate

AFCG

CNBS

CRLBF

FLWPF

GRWG

GTBIF

HENC

HEXO

IMCC

MMNFF

MSOS

THCX

TLLTF

YCBD

YOLO

CSE:GTII

TSX:HEXO

CSE:FFNT

CSE:CL

CSE:MMEN

CSE:TILT

Major earnings reports, financings, M&amp;A announcements and policy moves flooded the cannabis industry this week. 

The Week In Cannabis: Banking, Insurance, NY, Earnings, Financings, M&amp;A, And More

The Greenrose Holding Co Units (1 Ord Share & 1 War)

WIIM

BIRK

Birkenstock Holdings shares are trading higher after the company reported better-than-expected Q4 financial results and issued FY25 guidance.

Heico shares are trading lower after the company reported mixed Q4 financial results.

Fiscal Year 2025 Outlook:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">• Net revenue</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$27.3 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">• Core operating margin (Non-GAAP)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">5.4%</td>
</tr>
<tr>
<td colspan="1" rowspan="1">• Core diluted earnings per share (Non-GAAP)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$8.75 per diluted share</td>
</tr>
<tr>
<td colspan="1" rowspan="1">• Adjusted free cash flow (Non-GAAP)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$1.2 billion</td>
</tr>
</tbody>
</table>
</figure>

Guidance

Jabil Expects FY25 Revenue Of $27.3B (Prior $27B) Vs $27.03B Est, Adj EPS Of $8.75 (Prior $8.65) Vs $8.69 Est

B of A Securities analyst Tazeen Ahmad maintains 4D Molecular Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FDMT#NASDAQ">FDMT</a>) with a Buy and lowers the price target from $79 to $46.

Price Target

Analyst Ratings

FDMT

B of A Securities Maintains Buy on 4D Molecular Therapeutics, Lowers Price Target to $46

BMO Capital analyst Kelly Bania reinstates Casey's General Stores (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CASY#NASDAQ">CASY</a>) with a Market Perform and raises the price target from $400 to $450.

Initiation

CASY

BMO Capital Reinstates Market Perform on Casey's General Stores, Raises Price Target to $450

JP Morgan analyst Doug Anmuth maintains Amazon.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>) with a Overweight and raises the price target from $250 to $280.

AMZN

JP Morgan Maintains Overweight on Amazon.com, Raises Price Target to $280

Second Quarter of Fiscal Year 2025 Outlook:
<figure class="table"> 
<table>
<tbody>
<tr>
<td colspan="1" rowspan="1">• Net revenue</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$6.1 billion to $6.7 billion</td>
</tr>
<tr>
<td colspan="1" rowspan="1">• U.S. GAAP operating income</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$183 million to $263 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">• U.S. GAAP diluted earnings per share</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$0.69 to $1.27 per diluted share</td>
</tr>
<tr>
<td colspan="1" rowspan="1">• Core operating income (Non-GAAP)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$286 million to $346 million</td>
</tr>
<tr>
<td colspan="1" rowspan="1">• Core diluted earnings per share (Non-GAAP)</td>
<td colspan="1" rowspan="1">&nbsp;</td>
<td colspan="1" rowspan="1">$1.60 to $2.00 per diluted share</td>
</tr>
</tbody>
</table>
</figure>
 &nbsp;

Jabil Expects Q2 Revenue Of $6.1B-$6.7B Vs $6.27B Est, Adj EPS Of $1.60-$2.00 Vs $1.79 Est

Coinbase&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/COIN#NASDAQ">COIN</a>) 2025 crypto market outlook highlights five major trends poised to define the cryptocurrency market in the coming year, with stablecoins, tokenization and <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42480856/donald-trump-pledges-to-do-something-great-with-crypto-heres-what-hes-done-so-far">a regulatory shift</a> leading the way.
<a href="https://www.benzinga.com/news/events/24/12/42348790/stablecoins-a-new-tool-for-us-dollar-dominance-global-financial-access">Stablecoins</a> remain crypto's ‘killer app', with market capitalization growing 48% in 2024 to reach $193 billion as of Dec. 1.
Coinbase expects this trend to accelerate, moving beyond trading to broader adoption in global commerce and capital flows. 
The <a href="https://www.coinbase.com/en-gb/blog/crypto-market-outlook-5-things-to-watch-in-2025">report</a> estimates stablecoin transaction volumes surpassed $27 trillion in 2024, three times higher than the previous year​.
The tokenization of <a href="https://www.benzinga.com/markets/cryptocurrency/24/11/41718097/how-unlocking-tokenized-real-world-assets-on-new-platforms-could-redefine-digital-finance">real-world assets</a> (RWA) is another key focus area, having grown over 60% to $13.5 billion in 2024.
Coinbase believes <a href="https://www.benzinga.com/news/events/24/11/42012198/a-new-era-how-tokenization-could-reduce-frictions-and-potentially-costs-in-finance">RWA tokenization</a> will streamline financial transactions and expand into areas like private credit, corporate bonds, real estate, and commodities​.
On the institutional front, the success of <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42550416/bitcoin-etfs-decline-as-king-crypto-falls-to-104000">spot Bitcoin ETFs</a> has reshaped demand dynamics, with Coinbase expecting further developments.
The potential approval of ETFs for XRP (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/xrp/usd">XRP</a>), Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>) and Litecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/ltc/usd">LTC</a>) could drive limited near-term demand.
However, innovations such as allowing in-kind creations or staking could significantly enhance ETF appeal by narrowing bid-ask spreads and improving alignment with net asset values​.
Also Read: <a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42537836/litecoin-hbar-etfs-could-come-before-xrp-solana-heres-why">Litecoin, HBAR ETFs Could Come Before XRP, Solana: Here&#8217;s Why</a>
<a href="https://www.benzinga.com/money/what-is-defi">Decentralized finance (DeFi)</a> is set for a resurgence.
After facing setbacks in the previous cycle, lending protocols and decentralized exchanges (DEXs) have shown resilience, hitting all-time highs in total value locked (TVL). 
Innovative applications like <a href="https://www.benzinga.com/money/what-is-depin">decentralized physical infrastructure</a> (DePIN) and prediction markets signal the sector&#8217;s evolution.
A pro-crypto regulatory shift in the United States is expected to provide much-needed clarity, with a bipartisan majority in Congress supporting crypto-friendly policies. 
Coinbase anticipates regulatory milestones, including stablecoin legislation and an end to regulation-by-enforcement. 
Globally, G20 countries and other financial hubs are also moving toward creating digital asset frameworks.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42526592/bitcoin-ethereum-etfs-see-688m-net-inflows-analysts-target-124000">Bitcoin, Ethereum ETFs See $688M Net Inflows, Analysts Target $124,000</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$LTC

$SOL

$XRP

COIN

Coinbase's 2025 Market Outlook Highlights 5 Major Trends To Come

Brookline Capital analyst Kumaraguru Raja initiates coverage on Quince Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QNCX#NASDAQ">QNCX</a>) with a Buy rating and announces Price Target of $9.

QNCX

Brookline Capital Initiates Coverage On Quince Therapeutics with Buy Rating, Announces Price Target of $9

DCGO

SHLT

DocGo Expands Collaboration With SHL Telemedicine, Integrating Smartheart For Advanced Mobile Health Services

Jabil shares are trading higher after the company reported better-than-expected Q1 EPS and revenues.

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies.
The RSI is a momentum indicator, which compares a stock&#8217;s strength on days when prices go up to its strength on days when prices go down. When compared to a stock&#8217;s price action, it can give traders a better sense of how a stock may perform in the short term. An asset is typically considered oversold when the<a href="https://www.benzinga.com/topic/rsi"> RSI is below 30</a>, according to <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
Here's the latest list of major oversold players in this sector, having an RSI near or below 30.
<h3 class="wp-block-heading">Silence Therapeutics PLC &#8211; ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLN#NASDAQ">SLN</a>)</h3>
<ul>
<li>On Dec. 10, Chardan Capital analyst Keay Nakae maintained Silence Therapeutics with a Buy and maintained a $55 price target. The company's stock fell around 41% over the past month and has a <a href="https://www.benzinga.com/quote/SLN">52-week low of $5.81</a>.</li>
<li>RSI Value: 26.72&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</li>
<li>SLN Price Action: Shares of Silence Therapeutics fell 3.4% to close at $6.51 on Tuesday.</li>
<li>Benzinga Pro's real-time newsfeed alerted to<a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"> latest SLN news</a>. </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="901" height="836" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151.png" alt="" class="wp-image-697338" style="width:586px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151.png 901w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151-300x278.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040816/image-151-768x713.png 768w" sizes="(max-width: 901px) 100vw, 901px" /></a></figure>
<h3 class="wp-block-heading">ModivCare Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MODV#NASDAQ">MODV</a>)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</h3>
<ul>
<li>On Nov. 6, ModivCare posted weaker-than-expected quarterly results. &#8220;This quarter has demonstrated positive momentum, reflected in both operational enhancements and strengthened relationships, even amid shifts in the broader healthcare market. We delivered solid third-quarter results, reporting $43 million of adjusted EBITDA and a 2% increase in consolidated revenue, driven primarily by 5% growth in our personal care services segment,&#8221; stated L. Heath Sampson, President and CEO. The company's stock fell around 26% over the past five days and <a href="https://www.benzinga.com/quote/MODV">has a 52-week low</a> of $11.00.</li>
<li>RSI Value: 28.52</li>
<li>MODV Price Action: Shares of ModivCare fell 11.4% to close at $14.10 on Tuesday.</li>
<li>Benzinga Pro&#8217;s charting tool helped identify the <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">trend in MODV stock.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="915" height="840" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152.png" alt="" class="wp-image-697341" style="width:603px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152.png 915w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152-300x275.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18040915/image-152-768x705.png 768w" sizes="(max-width: 915px) 100vw, 915px" /></a></figure>
<h3 class="wp-block-heading">Olema Pharmaceuticals Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OLMA#NASDAQ">OLMA</a>)</h3>
<ul>
<li>On Dec. 10, Olema Oncology presented updated clinical results for Palazestrant in combination with Ribociclib at the San Antonio Breast Cancer Symposium. The company's stock fell around 37% over the past five days and has a 52-week <a href="https://www.benzinga.com/quote/OLMA">low of $6.08</a>.</li>
<li>RSI Value: 23.69</li>
<li>OLMA Price Action: Shares of Olema Pharmaceuticals fell 4.7% to close at $6.14 on Tuesday.</li>
<li>Benzinga Pro&#8217;s signals feature notified of a potential <a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1">breakout in OLMA shares.</a> </li>
</ul>
<figure class="wp-block-image size-full is-resized"><a href="https://bzresearch.myclickfunnels.com/benzinga-pro-content-webinar-registration/?utm_source=BZprocontent121824&amp;t=be2bearmibe3na1"><img loading="lazy" decoding="async" width="898" height="842" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153.png" alt="" class="wp-image-697342" style="width:639px;height:auto" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153.png 898w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153-300x281.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/12/18041039/image-153-768x720.png 768w" sizes="(max-width: 898px) 100vw, 898px" /></a></figure>
Read This Next: 
<ul>
<li><a href="https://www.benzinga.com/24/12/42531171/top-2-utilities-stocks-that-could-sink-your-portfolio-this-quarter">Top 2 Utilities Stocks That Could Sink Your Portfolio This Quarter</a></li>
</ul>

Long Ideas

Pre-Market Outlook

Trading Ideas

MODV

OLMA

Top 3 Health Care Stocks That May Explode In Q4

Earnings

Earnings Beats

Jabil Q1 2025 Adj. EPS $2.00 Beats $1.88 Estimate, Sales $6.994B Beat $6.608B Estimate

Study Builds on Extensive Published Literature Highlighting the Benefits of the CyberKnife System in the Treatment of a Wide Range of Neurological Indications

ARAY

Accuray's CyberKnife System Offers Promising Outcomes For Brainstem Metastases, Highlighting Safety And Precision

Northland Capital Markets analyst Bobby Brooks maintains Excelerate Energy (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EE#NYSE">EE</a>) with a Outperform and raises the price target from $29 to $37.

Northland Capital Markets Maintains Outperform on Excelerate Energy, Raises Price Target to $37

Salesforce&nbsp;Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CRM#NYSE">CRM</a>) targets employing 2,000 people in the form of sales reps, marketers, and customer service agents to sell <a target="_blank" href="https://www.benzinga.com/topic/ai" rel="noreferrer noopener">artificial intelligence</a> software to clients, CNBC <a target="_blank" href="https://www.cnbc.com/2024/12/17/salesforce-will-hire-2000-people-to-sell-ai-products-benioff-says.html" rel="noreferrer noopener">cited</a> CEO Marc Benioff at a company event in San Francisco on Tuesday.
In November, Benioff shared plans to employ 1,000 salespeople focusing on AI. Benioff told CNBC Salesforce already had 9,000 referrals for the 2,000 positions.
Also Read: <a target="_blank" href="https://www.benzinga.com/tech/24/12/42536593/verizon-teams-up-with-nvidia-to-power-ai-apps-over-private-5g-networks" rel="noreferrer noopener">Verizon Teams Up With Nvidia To Power AI Apps Over Private 5G Networks</a>
On Tuesday, Salesforce announced that a second generation&nbsp;of its Agentforce technology, capable of tackling questions in Salesforce's Slack communications app, will be <a target="_blank" href="https://www.benzinga.com/pressreleases/24/12/b42537776/introducing-agentforce-2-0-the-digital-labor-platform-for-building-a-limitless-workforce" rel="noreferrer noopener">available in February 2025</a>.
Salesforce has embedded experimental AI agents on its homepage to enhance user interaction. It manages 32,000 weekly queries through its chat-based help page, with only 5,000 requiring human escalation, down from 10,000.
Benioff highlighted these advancements as evidence of AI's growing role in improving customer support efficiency.
Benioff contrasted Salesforce's offerings with Microsoft Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>), noting the limited visibility of its Copilot-branded AI tools. Microsoft countered, stating that its AI solutions are driving measurable improvements, including a 9.4% boost in revenue per seller and an 11.5% reduction in case resolution time.
Salesforce's hiring spree comes nearly two years after the company laid off over 7,000 employees to adjust to economic conditions.
On Tuesday, Salesforce and Adecco Group boosted recruiting with Agentforce and Data Cloud for <a target="_blank" href="https://www.benzinga.com/news/contracts/24/12/42532242/salesforce-supercharges-adecco-vivint-with-ai-details" rel="noreferrer noopener">faster candidate matching</a>. Vivint, a provider of smart home and security solutions, tapped Agentforce to enhance its customer service&nbsp;teams with 24/7 autonomous agent support.
On TechCrunch's Equity podcast, Benioff <a target="_blank" href="https://techcrunch.com/2024/12/17/salesforce-plans-to-hire-2000-people-to-sell-its-ai-products/" rel="noreferrer noopener">predicted</a> that Salesforce will surpass a billion agents within the next 12 months. In October, Northland Capital Partners <a target="_blank" href="https://www.benzinga.com/top-stories/24/10/41145130/salesforces-genai-platform-agentforce-on-par-with-microsoft-analyst" rel="noreferrer noopener">stated that the</a> AgentForce platform now matches Microsoft's capabilities.
Salesforce&nbsp;stock surged over 37% year-to-date.
Salesforce reported <a target="_blank" href="https://www.benzinga.com/news/earnings/24/12/42302924/salesforce-q3-earnings-revenue-beat-eps-miss-free-cash-flow-up-30-ai-driving-groundbreaking-transformation-and-more" rel="noreferrer noopener">a third-quarter revenue</a> of $9.44 billion, up 8%, above the&nbsp;analyst consensus of $9.35 billion. The adjusted EPS of $2.41 missed the analyst consensus of $2.44.
Salesforce expects fourth-quarter revenue of $9.9 billion-$10.1 billion versus $10.04 billion analyst consensus. It anticipates fourth-quarter adjusted EPS of $2.57-$2.62 compared to consensus estimate of $2.61.&nbsp;
Investors can gain exposure to Salesforce through JPMorgan Equity Premium Income ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/JEPI#NYSE">JEPI</a>) and SPDR Series Trust SPDR Portfolio S&amp;P 500 Growth ETF (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPYG#NYSE">SPYG</a>).
Price Action: CRM stock traded higher by 0.71% to $353.47 premarket at the last check on Wednesday.
Also Read:
<ul>
<li><a href="https://www.benzinga.com/24/12/42536024/taiwan-eyes-amazons-kuiper-as-starlink-faces-hurdles" target="_blank" rel="noreferrer noopener">Amazon's Project Kuiper In Talks With Taiwan For Satellite Partnership</a></li>
</ul>
Photo via Shutterstock

Tech

Media

JEPI

MSFT

SPYG

Salesforce Doubles AI Hiring Goal, To Add 2K Sales Roles

NIO Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NIO#NYSE">NIO</a>) shares are experiencing a rise in premarket trading on Wednesday, as the company officially gears up for the launch of its new sub-brand, Firefly, which <a target="_blank" href="https://www.benzinga.com/movers" rel="noreferrer noopener">is set to be unveiled this weekend.</a>
The Firefly brand, focused on premium smart electric vehicles for global urban consumers, made a significant step forward today with the launch of its official WeChat account, mini-program, and mobile app, <a target="_blank" href="https://cnevpost.com/2024/12/18/nio-warming-up-firefly-logo-app/" rel="noreferrer noopener">reports</a> CnEV Post.
The brand also revealed its logo for the first time.
Firefly draws inspiration from the firefly insect, known for its glowing, self-illuminating nature. The brand describes itself as small, agile, energetic, and dynamic, targeting a younger, urban audience.
In addition to Firefly&#8217;s preparations, NIO also shared six new images of its ET9 sedan on Weibo, featuring a sleek blue exterior and highlighting several design details, CnEV Post <a target="_blank" href="https://cnevpost.com/2024/12/18/nio-new-images-et9/" rel="noreferrer noopener">writes</a>.
Also Read: <a target="_blank" href="https://www.benzinga.com/trading-ideas/previews/24/12/42549182/us-stocks-to-open-higher-as-rate-cut-expectations-surge-all-eyes-on-dow-jones-to-break-its-9-day-losing-streak" rel="noreferrer noopener">US Stocks To Open Higher As Rate Cut Expectations Surge: All Eyes On Dow Jones To Break Its 9-Day Losing Streak</a>
This comes just before Nio Day 2024, which will take place this Saturday in Guangzhou, Guangdong province. The event will spotlight the Firefly sub-brand and its debut model, along with the official launch of the Nio ET9.
The Nio ET9, which was first revealed at Nio Day 2023, carries a pre-sale price of RMB 800,000, making it the most expensive vehicle in Nio&#8217;s lineup.
Deliveries are expected to begin in the first quarter of 2025, marking a key expansion of Nio&#8217;s product range to appeal to a broader market.
Price Action: NIO shares are trading higher by 1.10% to $4.59 premarket at last check Wednesday.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/general/market-summary/24/12/42548385/fund-managers-increase-allocation-to-banking-and-insurance-stocks-in-december-here-are-the-best-performing-financial-stocks-in-2024" target="_blank" rel="noreferrer noopener">Fund Managers Increase Allocation To Banking And Insurance Stocks In December: Here Are The Best Performing Financial Stocks In 2024</a></li>
</ul>
Photo by Sundry Photography on Shutterstock.

Equities

Movers

Personal Finance

General

What's Going On With NIO Stock Today?

Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>) continues to trend downward, reflecting broader stagnation in <a href="https://www.benzinga.com/trading-ideas/movers/24/12/42545419/bitcoin-ethereum-dogecoin-stay-muted-before-feds-interest-rate-decision-analyst-says-btc-in-parabolic-phase-reveals-its-duration">the cryptocurrency market</a>.   
<figure class="wp-block-table"> 
<table>
<tbody>
<tr>
<td>Cryptocurrency</td>
<td>Price&nbsp;&nbsp;&nbsp;</td>
<td>Market Cap</td>
<td>24-Hour Trend</td>
<td>7-Day Trend</td>
</tr>
<tr>
<td>Dogecoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/doge/usd">DOGE</a>)</td>
<td>$0.3885</td>
<td>$57.2 billion</td>
<td>-4.1%</td>
<td>-3.6%</td>
</tr>
<tr>
<td>Shiba Inu (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/shib/usd">SHIB</a>)</td>
<td>$0.00002602</td>
<td>$15.3 billion</td>
<td>-4.7%</td>
<td>-5.9%</td>
</tr>
<tr>
<td>Pepe (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/">PEPE</a>)</td>
<td>$0.00002179</td>
<td>$9.2 billion</td>
<td>-7.2%</td>
<td>-8.4%</td>
</tr>
</tbody>
</table>
</figure>
Trader Notes: Crypto trader More Crypto Online notes that Dogecoin&#8217;s recent 4% drop means the price stuck in a consolidation phase. 
He <a href="https://x.com/Morecryptoonl/status/1869217158040879159">suggests</a> that holding above $0.365 could open the door for an upside breakout, but a drop below this level might direct attention to the $0.25–$0.337 support zone.
Crypto chart analyst Ali Martinez highlights negative market sentiment surrounding Dogecoin, attributing the current price stagnation to trader impatience during this extended consolidation period.
<figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"> 
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true">Market sentiment for <a href="https://twitter.com/hashtag/Dogecoin?src=hash&amp;ref_src=twsrc%5Etfw">#Dogecoin</a> <a href="https://twitter.com/search?q=%24DOGE&amp;src=ctag&amp;ref_src=twsrc%5Etfw">$DOGE</a> has turned negative. It seems as if traders are getting impatient during the ongoing price consolidation! <a href="https://t.co/yb29147Bvg">pic.twitter.com/yb29147Bvg</a>
&mdash; Ali (@ali_charts) <a href="https://twitter.com/ali_charts/status/1869119123919183935?ref_src=twsrc%5Etfw">December 17, 2024</a></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
</figure>
Crypto trader Kevin <a href="https://x.com/Kev_Capital_TA/status/1869159630045081778">adds</a> that Dogecoin continues to face resistance, failing to reclaim the Macro .786 Fib level for over a week and losing support at the Macro .5 Fib on the linear chart. 
He also points out bearish signals for Bitcoin, which faces rejection at its Macro 1.703 Fib level, alongside substantial downside liquidity risks.
Kevin believes the market&#8217;s short-term outlook leans bearish, given the Federal Reserve&#8217;s potential rate pause and the Bank of Japan&#8217;s anticipated rate hike.
Statistics: According to Coinglass, Dogecoin short liquidations have dropped to $629,800, the lowest level since Oct. 13.
Additionally, spot trading data shows continuous negative net flows since Dec. 12, with a net outflow of $34.3 million as of Dec.18.
Read Next:&nbsp;
<ul>
<li><a href="https://www.benzinga.com/markets/cryptocurrency/24/12/42488734/dogecoin-price-stuck-around-40-cents-why-isnt-doge-moving">Dogecoin Price Stuck Around 40 Cents: Why Isn&#8217;t DOGE Moving?</a></li>
</ul>
Image: Shutterstock

$DOGE

$PEPE

$SHIB

Dogecoin Down Another 4% As Sentiment Sours: What Is Going On?

JP Morgan analyst Doug Anmuth maintains Alphabet (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) with a Overweight and raises the price target from $212 to $232.

GOOGL

JP Morgan Maintains Overweight on Alphabet, Raises Price Target to $232

JMP Securities analyst Aaron Kimson initiates coverage on Blend Labs (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BLND#NYSE">BLND</a>) with a Market Outperform rating and announces Price Target of $7.

BLND

JMP Securities Initiates Coverage On Blend Labs with Market Outperform Rating, Announces Price Target of $7

Comments

The Greenrose Holding Co Units (1 Ord Share & 1 War)

The Greenrose Holding Co Units (1 Ord Share & 1 War) (GNRSU) Options

No option chain data available. Please try again later

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga